Publication:
Mass spectrometry-based untargeted metabolomics study of non-obese individuals with non-alcoholic fatty liver disease

Loading...
Thumbnail Image
Date
2023-06-01
Authors
Demirel M.
Köktaşoğlu F.
Özkan E.
Dulun Ağaç H.
Gül A. Z.
Sharifov R.
Sarıkaya U.
Başaranoğlu M.
Selek Ş.
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Objectives: Non-alcoholic fatty liver disease (NAFLD) is a disease characterized by the accumulation of excessive fat in the liver, which can lead to fibrosis and has an increasing prevalence. NAFLD requires non-invasive diagnostic biomarkers. While typically observed in overweight individuals, it can also occur in non-obese/non-overweight individuals. Comparative studies on non-obese NAFLD patients are scarce. This study aimed to conduct a using liquid chromatography-high resolution mass spectrometry (LC-MS/MS)-based metabolic profiling of non-obese NAFLD patients and healthy controls. Materials and methods: The patient group consisted of 27 individuals with NAFLD, while the healthy control group included 39 individuals. Both groups were between 18 and 40 years old, had a BMI of less than 25 and had alcohol consumption less than 20 g/week for men and 10 g/week for women. Serum samples were collected and analyzed using LC-MS/MS. The data were analyzed using the TidyMass and MetaboAnalyst. Results: The LC-MS/MS analyses detected significant changes in D-amino acid metabolism, vitamin B6 metabolism, apoptosis, mTOR signaling pathway, lysine degradation, and phenylalanine metabolism pathways in non-obese NAFLD patients. Significant changes were also observed in the metabolites D-pantothenic acid, hypoxanthine, citric acid, citramalic acid, L-phenylalanine, glutamine, and histamine-trifluoromethyl-toluidide, β-hydroxymyristic acid, DL-Lactic acid, and 3-methyl-2-oxopentanoic. Overall, the study provides valuable insights into the metabolic changes associated with non-obese NAFLD patients and can contribute to the development of non-invasive diagnostic biomarkers for NAFLD.
Description
Keywords
Metabolomics, metabolites, nafld, non-alcoholic fatty liver disease, non-obese
Citation
Demirel M., Köktaşoğlu F., Özkan E., Dulun Ağaç H., Gül A. Z., Sharifov R., Sarıkaya U., Başaranoğlu M., Selek Ş., "Mass spectrometry-based untargeted metabolomics study of non-obese individuals with non-alcoholic fatty liver disease", SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, cilt.0, 2023
Page Views

9

File Downloads

26

Sustainable Development Goals